Published September 30, 1991
| Version v1
Journal article
Radiolabelling of polymer microspheres for scintigraphic investigations by neutron activation. 1
- 1. University of Nottingham (United Kingdom). Department of Pharmaceutical Sciences
- 2. University of Nottingham (United Kingdom). Department of Mining Engineering
- 3. University of Nottingham (United Kingdom). Department of Physiology and Pharmacology
Description
Eudragit RS: sulphasalazine microspheres containing 0.08 percent w/w samarium oxide (Sm2O3) have been produced using a conventional emulsification-solvent evaporation technique. Direct quantification of incorporated Sm2O3 was achieved using X-ray fluorescence spectroscopy. The efficiency of Sm2O3 incorporation increased with concentration but microsphere yield, appearance , drug content and drug release rate were unaffected by Sm2O3 content over the concentration range investigated. Incorporation of Sm2O3 by solvent evaporation would appear to offer a convenient method for producing microspheres to be radiolabelled by neutron activation for use in scintigraphic studies. (author). 8 refs.; 1 fig.; 2 tabs
Additional details
Additional titles
- Subtitle (English)
- Incorporation of samarium oxide and its effects on the properties of Eudragit RS : sulphasalazine microspheres
Publishing Information
- Journal Title
- International Journal of Pharmaceutics
- Journal Volume
- 76
- Journal Issue
- 1,2
- Series
- Int. J. Pharm.
- Journal Page Range
- 55-59
- ISSN
- 0378-5173
- CODEN
- IJPHD
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- Netherlands
- INIS RN
- 23031441
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- DRUGS; SAMARIUM OXIDES; SCINTISCANNING; X-RAY FLUORESCENCE ANALYSIS
- Descriptors DEC
- CHALCOGENIDES; CHEMICAL ANALYSIS; COUNTING TECHNIQUES; DIAGNOSTIC TECHNIQUES; NONDESTRUCTIVE ANALYSIS; OXIDES; OXYGEN COMPOUNDS; RADIOISOTOPE SCANNING; RARE EARTH COMPOUNDS; SAMARIUM COMPOUNDS; X-RAY EMISSION ANALYSIS
Optional Information
- Notes
- P.J. Watts was supported by fund from SERC and Reckitt and Colman Products.